Page 306 - fbkCardioDiabetes_2017
P. 306

282                           Cardio Diabetes Medicine 2017







                                 Role  of  Nerve  Conduction

                                 Study  in  Diabetic  Patients




                                                      Dr. B. Kannan
                                            MD., DM (Neuro), Consultant  Neurologist,
                                              Sundaram Arulrhaj Hospitals, Tuticorin
                          Senior  Assistant  Professor, Thoothukudi Medical College  Hospital, Tamil Nadu

                                     Dr. Princy John P, DNB Resident    Medicine



              ABSTRACT                                           have been excluded. A  more  detailed  definition of
                - Peripheral  Neuropathy is one of the  commonest   Diabetic neuropathy  was  previously  agreed  upon at
                complication in Diabetic patients.               the San Antonio Consensus Conference:

                - Nerve  Conduction Study is useful to assess  in-  “Diabetic  neuropathy is  a descriptive  term meaning
                volvement  of Neuropathy  in Diabetic  patients es-  a demonstrable  disorder,  either clinically evident or
                pecially Large fibre.                            subclinical, that occurs in the setting of diabetes mel-
                                                                 litus without other causes for peripheral neuropathy.
                - In Diabetic patients Nerve Conduction studies pre-  The neuropathic disorder includes manifestations in
                dominantly will  show axonal   type  of  Peripheral   the somatic and/or autonomic parts of the peripheral
                Neuropathy.                                      nervous system”

              Introduction                                       Epidemiology
              Peripheral Neuropathy is inflammation and degener-    - Occurs in Type I and Type II Diabetes Mellitus
              ation of the peripheral nerves and the cranial nerves
              resulting  in impairment of the conductivity  of these     - Occurs in 42% of Type II Diabetes Mellitus
              nerves. Peripheral neuropathy may be classified:     - Onset within 10 years of disease

                - According to the number and distribution of nerves     - Higher risk with higher Glycosylated Hemoglobin
                affected  (mononeuropathy,  mononeuritis  multi-
                plex or polyneuropathy)                          What causes Diabetic Neuropathy?
                - The type of nerve cell predominantly affected (mo-  • Metabolic factors -  such  as  high blood  glucose,
                tor, sensory, autonomic) or                        long duration of diabetes, abnormal blood fat lev-
                                                                   els, and possibly low levels of insulin
                - The  process  affecting the nerves;  e.g.,  inflamma-
                tion (neuritis), compression(compressionneuropa-  • Neurovascular  factors, leading  to damage  to the
                thy chemotherapy(chemotherapy-induced periph-      blood  vessels  that  carry  oxygen  and nutrients to
                eral neuropathy).                                  nerves
              Etiology can be Genetic diseases, Metabolic,   e n -  • Autoimmune  factors that  cause inflammation  in
              docrine diseases, Toxic causes,     Inflammatory     nerves
              diseases,Vitamin  deficiency ,Physical trauma,Che-  • Mechanical injury to nerves
              motherapy or Other causes including, electric shock,
              HIV,  malignant disease,  radiation, shingles  (Herpes   • Lifestyle factors, such as smoking or alcohol use .
              zoster a viral infection).
                                                                 Classification of Diabetic Neuropathy
              People with diabetes have a high risk of neuropathy.
              Diabetic Neuropathy can be defined as the presence   • Generalized Symmetrical Polyneuropathies
              of  symptoms  and/or  signs  of  peripheral  nerve  dys-  • Distal sensory or sensorimotor polyneuropathy
              function  in people  with diabetes  after  other  causes


                                                         GCDC 2017
   301   302   303   304   305   306   307   308   309   310   311